Cargando…

Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization

Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to elimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Ghufran, Nawaz, Asif, Latif, Muhammad Shahid, Shah, Kifayat Ullah, Ahmad, Saeed, Javed, Fatima, Alfatama, Mulham, Abd Ghafar, Siti Aisyah, Lim, Vuanghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858428/
https://www.ncbi.nlm.nih.gov/pubmed/36661809
http://dx.doi.org/10.3390/gels9010043
_version_ 1784874097540333568
author Ullah, Ghufran
Nawaz, Asif
Latif, Muhammad Shahid
Shah, Kifayat Ullah
Ahmad, Saeed
Javed, Fatima
Alfatama, Mulham
Abd Ghafar, Siti Aisyah
Lim, Vuanghao
author_facet Ullah, Ghufran
Nawaz, Asif
Latif, Muhammad Shahid
Shah, Kifayat Ullah
Ahmad, Saeed
Javed, Fatima
Alfatama, Mulham
Abd Ghafar, Siti Aisyah
Lim, Vuanghao
author_sort Ullah, Ghufran
collection PubMed
description Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to eliminate Helicobacter pylori (H. pylori) in the gastrointestinal tract. The bilayer tablets were prepared by means of the direct compression technique. The controlled-release bilayer tablets were prepared using various hydrophilic swellable polymers (sodium alginate, chitosan, and HPMC-K15M) alone and in combination to investigate the percent of swelling behavior and average drug release. The weight of the controlled-release floating layer was 500 mg, whereas the weight of the floating tablets of pantoprazole was 100 mg. To develop the most-effective formulation, the effects of the experimental components on the floating lag time, the total floating time, T 50%, and the amount of drug release were investigated. The drugs’ and excipients’ compatibilities were evaluated using ATR-FTIR and DSC. Pre-compression and post-compression testing were carried out for the prepared tablets, and they were subjected to in vitro characterization studies. The pantoprazole layer of the prepared tablet demonstrated drug release (95%) in 2 h, whereas clarithromycin demonstrated sustained drug release (83%) for up to 24 h (F7). The present study concluded that the combination of sodium alginate, chitosan, and HPMC polymers (1:1:1) resulted in a gastro-retentive and controlled-release drug delivery system of the drug combination. Thus, the formulation of the floating bilayer tablets successfully resulted in a biphasic drug release. Moreover, the formulation (F7) offered the combination of two drugs in a single-tablet formulation containing various polymers (sodium alginate, chitosan, and HPMC polymers) as the best treatment option for local infections such as gastric ulcers.
format Online
Article
Text
id pubmed-9858428
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98584282023-01-21 Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization Ullah, Ghufran Nawaz, Asif Latif, Muhammad Shahid Shah, Kifayat Ullah Ahmad, Saeed Javed, Fatima Alfatama, Mulham Abd Ghafar, Siti Aisyah Lim, Vuanghao Gels Article Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to eliminate Helicobacter pylori (H. pylori) in the gastrointestinal tract. The bilayer tablets were prepared by means of the direct compression technique. The controlled-release bilayer tablets were prepared using various hydrophilic swellable polymers (sodium alginate, chitosan, and HPMC-K15M) alone and in combination to investigate the percent of swelling behavior and average drug release. The weight of the controlled-release floating layer was 500 mg, whereas the weight of the floating tablets of pantoprazole was 100 mg. To develop the most-effective formulation, the effects of the experimental components on the floating lag time, the total floating time, T 50%, and the amount of drug release were investigated. The drugs’ and excipients’ compatibilities were evaluated using ATR-FTIR and DSC. Pre-compression and post-compression testing were carried out for the prepared tablets, and they were subjected to in vitro characterization studies. The pantoprazole layer of the prepared tablet demonstrated drug release (95%) in 2 h, whereas clarithromycin demonstrated sustained drug release (83%) for up to 24 h (F7). The present study concluded that the combination of sodium alginate, chitosan, and HPMC polymers (1:1:1) resulted in a gastro-retentive and controlled-release drug delivery system of the drug combination. Thus, the formulation of the floating bilayer tablets successfully resulted in a biphasic drug release. Moreover, the formulation (F7) offered the combination of two drugs in a single-tablet formulation containing various polymers (sodium alginate, chitosan, and HPMC polymers) as the best treatment option for local infections such as gastric ulcers. MDPI 2023-01-04 /pmc/articles/PMC9858428/ /pubmed/36661809 http://dx.doi.org/10.3390/gels9010043 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ullah, Ghufran
Nawaz, Asif
Latif, Muhammad Shahid
Shah, Kifayat Ullah
Ahmad, Saeed
Javed, Fatima
Alfatama, Mulham
Abd Ghafar, Siti Aisyah
Lim, Vuanghao
Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title_full Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title_fullStr Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title_full_unstemmed Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title_short Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
title_sort clarithromycin and pantoprazole gastro-retentive floating bilayer tablet for the treatment of helicobacter pylori: formulation and characterization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858428/
https://www.ncbi.nlm.nih.gov/pubmed/36661809
http://dx.doi.org/10.3390/gels9010043
work_keys_str_mv AT ullahghufran clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT nawazasif clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT latifmuhammadshahid clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT shahkifayatullah clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT ahmadsaeed clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT javedfatima clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT alfatamamulham clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT abdghafarsitiaisyah clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization
AT limvuanghao clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization